Osteologix to Highlight Osteoporosis Drug Opportunity at the Rodman and Renshaw 11th Annual Healthcare ConferenceGlen Allen, VAˇXSeptember 8, 2009--Osteologix, Inc. (OTCBB: OLGX) today announced that in light of recent announcements and set-backs in the field of Osteoporosis, the company believes it is positioned to take advantage of a significant gap in the market, and will discuss its development of a safe and effective treatment for Osteoporosis at the Rodman and Renshaw 11th Annual Healthcare Conference. Philip J. Young, President and CEO of Osteologix, will present the companyˇ¦s corporate overview at 10:50 a.m. ET on Wednesday, September 9, at the New York Palace Hotel in New York City. The live audio webcast and slide presentation can be accessed by visiting www.osteologix.com and clicking the link provided under ˇ§Latest Newsˇ¨.